Heliax AG – Trademark Portfolio
Entity Type: 03
Heliax AG holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 6 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include JUVIX and HELIAX.
Baarerstrasse 82
CH-6300 Zug
Showing of trademarks Trademarks
Trademark Classifications
Heliax AG's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Legal services; security services for the protection of property and individuals
Frequently Asked Questions
How many trademarks does Heliax AG have?
Heliax AG has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.
What trademark classes does Heliax AG file in?
Heliax AG files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 45 (Legal & Security Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Heliax AG's most well-known trademarks?
Heliax AG's registered trademark portfolio includes well-known marks such as JUVIX and HELIAX. These are among 2 currently registered trademarks in the portfolio.
What is Heliax AG's trademark registration success rate?
Heliax AG has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.